IL-13-induced airway mucus production is attenuated by MAPK13 inhibition

Journal of Clinical Investigation

Volumn 122, Issue 12, 2012, Pages 4555-4568

  Alevy, Yael G ^a   Patel, Anand C ^a   Romero, Arthur G ^a   Patel, Dhara A ^a   Tucker, Jennifer ^a   Roswit, William T ^a   Miller, Chantel A ^a   Heier, Richard F ^a   Byers, Derek E ^a   Brett, Tom J ^a   Holtzman, Michael J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CHLORIDE CHANNEL; CHLORIDE CHANNEL CALCIUM ACTIVATED 1; CHLORIDE CHANNEL CALCIUM ACTIVATED 2; CHLORIDE CHANNEL CALCIUM ACTIVATED 3; CHLORIDE CHANNEL CALCIUM ACTIVATED 4; DORAMAPIMOD; DOXYCYCLINE; INTERLEUKIN 13; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 13; MITOGEN ACTIVATED PROTEIN KINASE 14; MUCIN 5AC; MUCIN 5B; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS MUCUS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SIGNAL TRANSDUCTION; UPREGULATION;

BINDING SITES; CELLS, CULTURED; CHLORIDE CHANNELS; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYDROGEN BONDING; INTERLEUKIN-13; KINETICS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 13; MODELS, MOLECULAR; MUCINS; MUCUS; NAPHTHALENES; PROTEIN BINDING; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PYRAZOLES; RESPIRATORY SYSTEM; RNA INTERFERENCE; SECRETORY PATHWAY;

EID: 84870520781     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI64896     Document Type: Article

References (69)

1. Kuyper LM, et al. Characterization of airway plugging in fatal asthma. Am J Med. 2003; 115(1):6-11. (Pubitemid 36831115)
2. Hogg JC, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645-2653. (Pubitemid 38787999)
3. Brito-Mutunayagam R, Appleton SL, Wilson DH, Ruffin RE, Adams RJ. Global initiative for chronic obstructive lung disease stage 0 is associated with excess FEV1 decline in a representative population sample. Chest. 2010;138(3):605-613.
4. Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev. 2006;86(1):245-278.
5. Wills-Karp M, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998; 282(5397):2258-2261. (Pubitemid 29004074)
6. Tyner JW, et al. Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest. 2006;116(2):309-321. (Pubitemid 43228348)
7. Grayson MH, et al. Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia. J Exp Med. 2007;204(11):2759-2769. (Pubitemid 350044797)
8. Kim EY, et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic inflammatory lung disease. Nat Med. 2008;14(6):633-640. (Pubitemid 351809546)
9. Kuperman DA, et al. Direct effects of interleukin- 13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med. 2002;8(8):885-889.
10. Li D, Gallup M, Fan N, Szymkowski DE, Basbaum CB. Cloning of the amino-terminal and 5′-flanking region of the human MUC5AC mucin gene and transcriptional up-regulation by bacterial exoproducts. J Biol Chem. 1998;273(12):6812-6820. (Pubitemid 28160344)
11. Hewson CA, Edbrooke MR, Johnston SL. PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-a, Ras/Raf, MEK, ERK and Sp-1-dependent mechanisms. J Mol Biol. 2004;344(3):683-695. (Pubitemid 39469213)
12. Atherton HC, Jones G, Danahay H. IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation. Am J Physiol Lung Cell Mol Physiol. 2003;285(3):L730-L739. (Pubitemid 37022875)
13. Kono Y, et al. Sphingosine kinase 1 regulates mucin production via ERK phosphorylation. Pulm Pharmacol Ther. 2010;23(1):36-42.
14. Patel AC, et al. Genetic segregation of airway disease traits despite redundancy of chloride channel calcium-activated (CLCA) family members. Physiol Genomics. 2006;25(3):502-513. (Pubitemid 43764772)
15. Patel AC, et al. Homologous mouse Clca3,5,6 and human hCLCA1,2,4 gene clusters control mucous cell metaplasia. Am J Respir Crit Care Med. 2007;175:A499.
16. Patel AC, Brett TJ, Holtzman MJ. The role of CLCA proteins in inflammatory airway disease. Annu Rev Physiol. 2009;71:425-449.
17. Gibson A, Lewis AP, Affleck K, Aitken AJ, Meldrum E, Thompson N. hCLCA1 and mCLCA3 are secreted non-integral membrane proteins and therefore are not ion channels. J Biol Chem. 2005;280(29):27205-27212. (Pubitemid 41040759)
18. Mundhenk L, Alfalah M, Elble RC, Pauli BU, Naim HY, Gruber AD. Both cleavage products of the mCLCA3 protein are secreted soluble proteins. J Biol Chem. 2006;281(40):30072-30080. (Pubitemid 44537015)
19. Goldstein DM, Kuglstatter A, Lou Y, Soth MJ. Selective p38α inhibitors clinically evaluated for the treatment of chronic inflammatory disorders. J Med Chem. 2010;53(6):2345-2353.
20. Nakano T, et al. Niflumic acid suppresses interleukin- 13-induced asthma phenotypes. Am J Respir Crit Care Med. 2006;173(11):1216-1221. (Pubitemid 43848391)
21. Kettle R, et al. Regulation of neuregulin 1β1-induced MUC5AC and MUC5B expression in human airway epithelium. Am J Respir Cell Mol Biol. 2010;42(4):472-481.
22. Kirkham S, Kolsum U, Rousseau K, Singh D, Vestbo J, Thornton DJ. MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178(10):1033-1039.
23. Sepper R, et al. Mucin5B expression by lung alveolar macrophages is increased in long-term smokers. J Leukoc Biol. 2012;92(2):319-324.
24. Leverkoehne I, Gruber AD. The murine mCLCA3 (alias gob-5) protein is located in the mucin granule membranes of intestinal, respiratory, and uterine goblet cells. J Histochem Cytochem. 2002;50(6):829-838. (Pubitemid 34721451)
25. Raiford KL, Park J, Lin K, Fang S, Crews AL, Adler KB. Mucin granule-associated proteins in human bronchial epithelial cells: the airway goblet cell "granulome". Respir Res. 2011;12:118.
26. Song KS, et al. Interleukin-1b and tumor necrosis factor-a induce MUC5AC overexpression through a mechanism involving ERK/p38 mitogen-activated protein kinases-MSK1-CREB activation in human airway epithelial cells. J Biol Chem. 2003;278(26):23243-23250. (Pubitemid 36830137)
27. Karaman MW, et al. A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol. 2008;26(1):127-132.
28. Yuan-chen Wu D, Wu R, Reddy SP, Lee YC, Chang MM. Distinctive epidermal growth factor receptor/ extracellular regulated kinase-independent and -dependent signaling pathways in the induction of airway mucin 5B and mucin 5AC expression by phorbol 12-myristate 13-acetate. Am J Pathol. 2007;170(1):20-32.
29. Kuma Y, Sabio G, Bain J, Shprio N, Marquez R, Cuenda A. BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo. J Biol Chem. 2005;280(20):19472- 19479. (Pubitemid 41379467)
30. Cuenda A, et al. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995;364(2):229-233.
31. Deslee G, et al. Cigarette smoke induces nucleic acid oxidation in lung fibroblasts. Am J Respir Cell Mol Biol. 2010;43(5):576-584.
32. Sabio G, et al. p38g regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J. 2005;24(6):1134-1145. (Pubitemid 40516597)
33. Boehm H-J, Flohr A, Stahl M. Scaffold hopping. Drug Discov Today. 2004;1(3):217-224. (Pubitemid 40197570)
34. Sun H, Tawa G, Wallqvist A. Classification of scaffold-hopping approaches. Drug Discov Today. 2012;17(7-8):310-324.
35. Pargellis C, et al. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat Struct Biol. 2002;9(4):268-272. (Pubitemid 34289898)
36. Kuglstatter A, et al. X-ray crystal structure of JNK2 complexed with the p38α inhibitor BIRB796: insights into the rational design of DFG-out binding MAP kinase inhibitors. Bioorg Med Chem Lett. 2010;20(17):5217-5220.
37. Liu Y, Gray NS. Rational design of inhibitors that bind to inactive kinase conformations. Nat Chem Biol. 2006;2(7):358-364. (Pubitemid 43936934)
38. Lee MR, Dominguez C. MAP kinase inhibitors: clinical results and an intimate look at their interactions with p38α protein. Curr Med Chem. 2005;12(25):2979-2994. (Pubitemid 41672487)
39. Huan C, et al. mCLCA4 ER processing and secretion requires luminal sorting motifs. Am J Physiol. 2008;295(1):C279-C287. (Pubitemid 352755814)
40. Hamann M, et al. Human Clca1 modulates anionic conduction of calcium-dependent chloride currents. J Physiol. 2009;587(pt 10):2255-2274.
41. Bothe MK, Braun J, Mundhenk L, Gruber AD. Murine mCLCA6 is an integral apical membrane protein of non-goblet cell enterocytes and co-localizes with the cystic fibrosis transmembrane conductance regulator. J Histochem Cytochem. 2008;56(5):495-509. (Pubitemid 351556492)
42. Braun J, Bothe MK, Mundhenk L, Beck CL, Gruber AD. Murine mCLCA5 is expressed in granular layer keratinocytes of stratified epithelia. Histochem Cell Biol. 2010;133(3):285-299.
43. Bothe MK, Mundhenk L, Kaup M, Weise C, Gruber AD. The murine goblet cell protein mCLCA3 is a zinc-dependent metalloprotease with autoproteolytic activity. Mol Cells. 2011;32(6):535-541.
44. Bothe MK, Mundhenk L, Beck CL, Kaup M, Gruber AD. Impaired autoproteolytic cleavage of mCLCA6, a murine integral membrane protein expressed in enterocytes, leads to cleavage at the plasma membrane instead of the endoplasmic reticulum. Mol Cells. 2012;33(3):251-257.
45. Yurtsever Z, et al. Self-cleavage of human CLCA1 by a novel internal metalloprotease domain controls calcium-activated chloride channel activation [published online ahead of print October 30, 2012]. J Biol Chem. doi: 10.1074/jbc.M112.410282.
46. Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK- activated protein kinases. Microbiol Mol Biol Rev. 2011;75(1):50-83.
47. Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J. 2010;429(3):403-417.
48. Duvvuri U, et al. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res. 2012;72(13):3270-3281.
49. Jiang Y, et al. Characterization of the structure and function of the fourth member of p38 group mitogen- activated protein kinases, p38delta. J Biol Chem. 1997;272(48):30122-20128.
50. Eckert RL, Efimova T, Balasubramanian S, Crish JF, Bone F, Dashti S. p38 mitogen-activated protein kinases on the body surface - a function for p38d. J Invest Dermatol. 2003;120(5):823-828. (Pubitemid 36529085)
51. Effimova T, Broome AM, Eckert RL. Protein kinase Cdelta regulates keratinocyte death and survivial by regulating activity and subcellular localization of a p38delta-extracellular signal-regulated kinase 1/2 complex. Mol Cell Biol. 2004;24(18):8167-8183. (Pubitemid 39167465)
52. Feijoo C, Campbell DG, Jakes R, Goedert M, Cuenda A. Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/ p38delta at Thr50 promotes microtubule assembly. J Cell Sci. 2005;118(pt 2):397-408. (Pubitemid 40277351)
53. Sumara G, et al. Regulation of PKD by the MAPK p38δ in insulin secretion and glucose homeostasis. Cell. 2009;136(2):235-248.
54. Tan FL, et al. p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion. Int J Cancer. 2009;126(10):2353-2361.
55. Schindler E, et al. p38delta Mitogen-activated protein kinase is essential for skin tumor development in mice. Cancer Res. 2009;69(11):4648-4655.
56. Renda T, et al. Increased activation of p38 MAPK in COPD. Eur Respir J. 2008;31(1):62-69.
57. Medicherla S, et al. p38a-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation. J Pharmacol Exp Ther. 2008;324(3):921-929. (Pubitemid 351397845)
58. Risco A, et al. p38g and p38d kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation. Proc Natl Acad Sci U S A. 2012;109(28):11200-11205.
59. Soth M, et al. 3-Amino-pyrazolo[3,4-d]pyrimidines as p38α kinase inhibitors: design and development to a highly selective lead. Bioorg Med Chem Lett. 2011;21(11):3452-3456.
60. Koeberle SC, et al. Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor. Nat Chem Biol. 2011;8(2):141-143.
61. Chung KF. p38 mitogen-activated protein kinase pathways in asthma and COPD. Chest. 2011;139(6):1470-1479.
62. Bannerjee A, Koziol-White C, Panettieri RJ. p38 MAPK inhibitors, IKK2 inhibitors, and TNFa inhibitors in COPD. Curr Opin Pharmacol. 2012;12(3):287-292.
63. Thavagnanam S, Parker JC, McBrien ME, Skibinski G, Heaney LG, Shields MD. Effects of IL-13 on mucociliary differentiation of pediatric asthmatic bronchial epithelial cells. Ped Res. 2011;69(2):95-100.
64. Stewart SA, et al. Stable silencing of gene expression in primary cells by retroviral delivery of RNAi. RNA. 2003;9(4):493-501. (Pubitemid 36356735)
65. Lidell ME, Bara J, Hansson GC. Mapping of the 45M1 epitope to the C-terminal cysteine-rich part of the human MUC5AC mucin. FEBS J. 2008;275(3):481-489.
66. Otwinowski Z, Minor W. Processing of x-ray diffraction data collected in oscillation mode. In: Carter CWJ, Sweet RM, eds. Methods in Enzymology: Macromolecular Crystallography. New York, New York, USA: Academic Press; 1997:307-326. (Pubitemid 27085611)
67. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J Appl Crystallogr. 2007;40(pt 4):658-674. (Pubitemid 47080256)
68. Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010;66(pt 4):486-501.
69. Adams PD, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66(pt 2):213-221.